研究单位：[1]Peking University People's Hospital[2]Peking University People's Hospital, Peking University Insititute of Hematology[3]Beijing Municipal Science & Technology Commission[4]Beijing Hospital[5]Qilu Hospital of Shandong University[6]Navy General Hospital, Beijing[7]Beijing Tongren Hospital[8]Beijing Hospital, Ministry of Health,Beijing,China,100044[9]Peking University People's Hospital, Peking University Insititute of Hematology,Beijing,China,100044[10]Beijing Tongren Hospital,Beijing,China[11]PLA Navy General Hospital,Beijing,China[12]Qilu Hospital, Shandong University,Jinan,Shandong,China
Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
